Patents by Inventor Guangsu ZHU

Guangsu ZHU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10968495
    Abstract: Provided is a strain CCFM8631 of Lactobacillus reuteri and use thereof. The strain CCFM8631 of Lactobacillus reuteri can significantly increase neurotransmitter 5-hydroxytryptamine level in peripheral blood, recover the hormone levels, for example testosterone and so on in peripheral blood of rat, normalize abnormal abundances of Blautia genus and Turicibacter genus, Oscillospira genus and Bifidobacterium genus in intestinal flora of rat affected by high-fat high-starch diet, show good tolerance to simulated gastrointestinal fluid and quickly colonize in intestinal, significantly improve pathological damages of tissues such as liver, duodenum and so on, and increase triglyceride and total cholesterol levels in serum and oral glucose tolerance of rat with metabolic syndrome caused by high-fat high-starch diet.
    Type: Grant
    Filed: August 23, 2018
    Date of Patent: April 6, 2021
    Assignee: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Fangli Ma, Wei Chen, Gang Wang, Guangsu Zhu, Yuanyuan Wang, Lingyun Xiao, Minghua Hu, Hao Zhang, Jianxin Zhao, Chung Wah Ma
  • Publication number: 20190112675
    Abstract: Provided is a strain CCFM8631 of Lactobacillus reuteri and use thereof. The strain CCFM8631 of Lactobacillus reuteri can significantly increase neurotransmitter 5-hydroxytryptamine level in peripheral blood, recover the hormone levels, for example testosterone and so on in peripheral blood of rat, normalize abnormal abundances of Blautia genus and Turicibacter genus, Oscillospira genus and Bifidobacterium genus in intestinal flora of rat affected by high-fat high-starch diet, show good tolerance to simulated gastrointestinal fluid and quickly colonize in intestinal, significantly improve pathological damages of tissues such as liver, duodenum and so on, and increase triglyceride and total cholesterol levels in serum and oral glucose tolerance of rat with metabolic syndrome caused by high-fat high-starch diet.
    Type: Application
    Filed: August 23, 2018
    Publication date: April 18, 2019
    Applicant: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Fangli MA, Wei CHEN, Gang WANG, Guangsu ZHU, Yuanyuan WANG, Lingyun XIAO, Minghua HU, Hao ZHANG, Jianxin ZHAO, Chung Wah MA
  • Publication number: 20190112674
    Abstract: Provided is a strain CCFM8630 of Bifidobacterium adolescentis and use thereof. The strain CCFM8630 of Bifidobacterium adolescentis can significantly increase neurotransmitter 5-hydroxytryptamine level in peripheral blood of rat, recover the hormone levels, for example testosterone and so on in peripheral blood of rat, normalize abnormal abundances of Bifidobacterium genus, Blautia genus and Turicibacter genus in intestinal flora of rat affected by high-fat high-starch diet, show pretty good tolerance to simulated gastrointestinal fluid and quickly colonize in intestinal, significantly improve pathological damages of tissues such as liver, duodenum and so on, and increase triglyceride and total cholesterol levels in serum and oral glucose tolerance of rat with metabolic syndrome caused by high-fat high-starch diet.
    Type: Application
    Filed: August 22, 2018
    Publication date: April 18, 2019
    Applicant: INFINITUS (CHINA) COMPANY LTD.
    Inventors: Yuanyuan WANG, Wei CHEN, Gang WANG, Guangsu ZHU, Fangli MA, Lingyun XIAO, Minghua HU, Hao ZHANG, Jianxin ZHAO, Chung Wah MA